Latest News Archive
Please select Category, Year, and then Month to display items
31 July 2020
|
Story Lacea Loader
As a public higher-education institution in South Africa with a responsibility to contribute to public discourse, the University of the Free State (UFS) will be presenting the 3rd UFS Thought-Leader Series in collaboration with Vrye Weekblad as part of the Vrystaat Literature Festival’s online initiative, VrySpraak-digitaal.
This year, higher-education institutions
globally are placed in the challenging context of COVID-19. Aware and grounded in the reality that the world will not return to the normality of pre-COVID-19, our responsibility as scholars still remains to contribute to public discourse and to offer
innovative solutions that will impact the lives of people nationally and globally in order to help them understand and adapt to a new world order.
Against this background and context, this year’s debates focus on ‘Post-COVID-19, Post-Crisis’,
with Health and Modelling, Politics, Economy, and Predictions for 2021 as the sub-themes. Placed in a COVID-19 context, and in lieu of the Vrystaat Arts Festival,
the series will be presented virtually in the form of one webinar per month during the period August 2020 to November 2020.
Date: 13 August 2020
Topic: Health
and Modelling
Time: 11:30-13:00
RSVP: Alicia Pienaar, pienaaran1@ufs.ac.za
Facilitator:
Max du Preez
Editor: Vrye Weekblad
Biography
Introduction and welcome:
Prof Francis Petersen
Rector and Vice-Chancellor, UFS
Panellists:
Prof Salim Abdool Karim
Director: Centre for the AIDS Programme of Research in South Africa (CAPRISA)
Chair: South African Ministerial Advisory Committee on COVID-19
Biography
Prof Glenda Gray
President and CEO: South African Medical Research Council (SAMRC)
Biography
Prof Felicity Burt
NRF-DST South African Research Chair in vector-borne and zoonotic pathogens research
Biography
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004